[PDF][PDF] INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES
MMSM Mustafa, N Marzuki, KM Kamal, NA Halim - 2019 - researchgate.net
It is well documented that blockade of angiotensin II type 1 receptor may interfere with the
progression of the inflammatory processes. The present study aims to evaluate the dose …
progression of the inflammatory processes. The present study aims to evaluate the dose …
[PDF][PDF] Ciglitazone, a PPARγ Inducer, Ameliorates Renal Pre-glomerular Production and Activity of Angiotensin II and TxA2 in Glycerol-Induced Acute Renal Failure
Z Yousefipour, H Hercule, L Truong… - … of Pharmacology and …, 2007 - researchgate.net
Peroxisome proliferator activated receptor γ (PPARγ), a nuclear transcription factor,
modulates vascular responses to angiotensin II (AII) or thromboxane A2 (TxA2) via …
modulates vascular responses to angiotensin II (AII) or thromboxane A2 (TxA2) via …
[PDF][PDF] Journal of Cardiovascular Pharmacology and
RA Elrashidy, ME Asker… - Pharmacology and …, 2012 - researchgate.net
Pioglitazone has been demonstrated to have beneficial effects on cardiovascular outcomes.
However, little is known about its effect on cardiac remodeling associated with diabetic …
However, little is known about its effect on cardiac remodeling associated with diabetic …
[PDF][PDF] Reduktion der diabetischen Kapillarschädigung im Herz-und Skelettmuskel durch einen PPAR-γ-Agonisten und einen Vasopeptidase-Inhibitor
A Ashoff - 2012 - d-nb.info
Der Diabetes mellitus wird im Wesentlichen als eine Störung des Glukosemetabolismus
betrachtet, die, je nachdem ob es sich um einen Diabetes mellitus Typ I oder Typ II handelt …
betrachtet, die, je nachdem ob es sich um einen Diabetes mellitus Typ I oder Typ II handelt …
Rosuvastatin Ameliorates the Development of Pulmonary Arterial Hypertension in the 1 TG (mRen2) 27 Rat 2 3 4 5
VG DeMarco, J Habibi, AT Whaley-Connell… - 2009 - journals.physiology.org
31 We recently reported that Ren2 rats exhibit pulmonary arterial hypertension (PAH), which
is, in part, 32 mediated by oxidative stress. Since HMG-CoA reductase inhibitors (statins) …
is, in part, 32 mediated by oxidative stress. Since HMG-CoA reductase inhibitors (statins) …
[PDF][PDF] エンドセリン‐1 の糖尿病性血管機能障害に対する役割と治療薬との関わり
松本貴之， マツモトタカユキ， 田口久美子… - 星薬科大学 …, 2014 - stella.repo.nii.ac.jp
2011, Triggle et al., 2012). 内皮細胞は, EDRF のみならず, 収縮因子 [endothelium-derived
contracting factor (EDCF)] も産生・遊離する (Figure 2). EDCF には, 本総説の主要テーマである …
contracting factor (EDCF)] も産生・遊離する (Figure 2). EDCF には, 本総説の主要テーマである …
[引用][C] PPAR Agonists and Cardiovascular Disease in Diabetes
C Anna C, T Merlin C - PPAR Research - Hindawi Publishing Corporation